Claims for Patent: 10,927,120
✉ Email this page to a colleague
Summary for Patent: 10,927,120
| Title: | CDK inhibitors |
| Abstract: | Compounds of Formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors. |
| Inventor(s): | Tavares; Francis X. (Durham, NC), Strum; Jay Copeland (Hillsborough, NC) |
| Assignee: | GI Therapeutics, Inc. (Research Triangle Park, NC) |
| Application Number: | 15/931,330 |
| Patent Claims: |
1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of the compound of the structure: ##STR00209## or a pharmaceutically
acceptable salt thereof; wherein the pharmaceutical composition is in the form of a liquid dosage form.
2. The pharmaceutical composition of claim 1, wherein the composition comprises between 1 and 1000 milligrams of the compound of the structure: ##STR00210## or a pharmaceutically acceptable salt thereof. 3. The pharmaceutical composition of claim 1, wherein the composition comprises between 1 and 500 milligrams of the compound of the structure: ##STR00211## or a pharmaceutically acceptable salt thereof. |
